Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hepatocellular Carcinoma Resectable × raltitrexed × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1 Mesothelioma, Malignant 1 Liver, Cancer of, Primary Resectable 1 Hepatocellular Carcinoma Resectable 1 Head and Neck Squamous Cell Cancer 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

raltitrexed 1 lobaplatin 1 Oxaliplatin 1 Leucovorin 1 Fluorouracil 1 Doxorubicin 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05766605 2023-03-13

Applicability of PDOX in Patients With Primary Liver Cancer: A Randomized Controlled Trial

Zhujiang Hospital

Phase 3 Unknown

Gastrointestinal

Hepatocellular Carcinoma Resectable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡